Onderneming AXIM Biotechnologies, Inc. Other OTC
Aandelen
AXIM
US05463V1008
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +345,27% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 0 | 100,0 % | 0 | 100,0 % | +345,27% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
John Huemoeller
CEO | Chief Executive Officer | 68 | - |
Robert Malasek
DFI | Director of Finance/CFO | 55 | 29-06-16 |
Kurt Phinney
COO | Chief Operating Officer | - | 23-05-23 |
Joseph Tauber
CTO | Chief Tech/Sci/R&D Officer | 67 | 21-09-21 |
Jeffrey A. Busby
PRN | Corporate Officer/Principal | - | 15-09-21 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
John Huemoeller
CEO | Chief Executive Officer | 68 | - |
Timothy Scott
BRD | Director/Board Member | 71 | 18-05-17 |
Director/Board Member | 76 | 18-05-17 | |
Blake Schroeder
BRD | Director/Board Member | 48 | - |
Peter O'Rourke
BRD | Director/Board Member | 76 | 21-07-20 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 500 000 | 0 | 0 | 71,61 % |
Aandeel B | 1 | 278 429 403 | 199 384 612 ( 71,61 %) | 0 |
Bedrijfsgegevens
AXIM Biotechnologies, Inc.
6191 Cornerstone Court East Suite 114
92121, San Diego
+
http://www.aximbiotech.comSector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+22,81% | 47,9 mld. | |
+46,56% | 41,42 mld. | |
-1,88% | 40,7 mld. | |
-6,20% | 28,92 mld. | |
+11,33% | 25,55 mld. | |
-21,00% | 19,27 mld. | |
-1,43% | 12,15 mld. | |
+30,73% | 12,14 mld. | |
-0,48% | 11,99 mld. |